Medical Properties Trust (NYSE:MPW) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Saturday.
A number of other brokerages also recently commented on MPW. Zacks Investment Research upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Wednesday. Stifel Nicolaus set a $14.00 price target on shares of Medical Properties Trust and gave the stock a “hold” rating in a report on Thursday, November 1st. JMP Securities set a $16.00 price target on shares of Medical Properties Trust and gave the stock a “buy” rating in a report on Monday, October 1st. Mitsubishi UFJ Financial Group lifted their price target on shares of Medical Properties Trust to $15.00 and gave the stock a “neutral” rating in a report on Friday, November 2nd. Finally, Jefferies Financial Group downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating and set a $15.00 price target for the company. in a report on Tuesday, July 17th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $14.19.
Shares of NYSE MPW opened at $16.72 on Friday. The stock has a market cap of $5.96 billion, a PE ratio of 12.39, a PEG ratio of 3.46 and a beta of 0.47. Medical Properties Trust has a 12 month low of $11.82 and a 12 month high of $16.85. The company has a quick ratio of 2.19, a current ratio of 4.92 and a debt-to-equity ratio of 0.90.
In related news, Director Michael G. Stewart sold 12,400 shares of the firm’s stock in a transaction that occurred on Friday, October 12th. The shares were sold at an average price of $14.13, for a total value of $175,212.00. Following the sale, the director now directly owns 231,039 shares of the company’s stock, valued at $3,264,581.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 22nd. The stock was sold at an average price of $14.93, for a total transaction of $1,493,000.00. Following the completion of the sale, the insider now directly owns 963,965 shares in the company, valued at $14,391,997.45. The disclosure for this sale can be found here. Insiders sold 127,400 shares of company stock worth $1,890,812 over the last three months. Corporate insiders own 0.83% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new stake in shares of Medical Properties Trust in the second quarter worth approximately $104,000. Cornerstone Wealth Management LLC acquired a new stake in shares of Medical Properties Trust in the second quarter worth approximately $583,000. Valeo Financial Advisors LLC acquired a new stake in shares of Medical Properties Trust in the second quarter worth approximately $128,000. Integrated Investment Consultants LLC acquired a new stake in shares of Medical Properties Trust in the second quarter worth approximately $136,000. Finally, Investors Asset Management of Georgia Inc. GA ADV acquired a new position in Medical Properties Trust during the second quarter valued at approximately $140,000. 77.17% of the stock is currently owned by institutional investors and hedge funds.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Recommended Story: Leveraged Buyout (LBO) Explained
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.